Skip to content

IEMbase 0590: PPA2-related mitochondrial inorganic pyrophosphatase 2 deficiency

Scope

Field Value
IEMbase ID 590
Nosology 11.4.01.01
Gene PPA2
External IDs OMIM:617222
Generated mapping UNMAPPED
Candidate DisMech targets Dilated_Cardiomyopathy.yaml#PPA2 (partial)
Review date 2026-07-07

IEMbase phenotype signal

IEMbase represents PPA2-related mitochondrial inorganic pyrophosphatase 2 deficiency, with alternate label infantile sudden cardiac failure / SCFI. The record is autosomal recessive, classified under miscellaneous disorders associated with mitochondrial dysfunction, has unknown treatability, and has no treatment rows.

Biochemical rows include increased plasma lactate. Clinical rows include seizures, cardiac arrhythmia, lactic acidosis, and sudden death.

DisMech phenotype coverage

No generated DisMech target was proposed. Dilated_Cardiomyopathy.yaml contains PPA2 as an autosomal recessive dilated-cardiomyopathy gene with ClinGen support and includes a mitochondrial dysfunction node that names PPA2. That is real gene-level and cardiac-disease-class coverage, but it is not an exact model of PPA2 mitochondrial inorganic pyrophosphatase deficiency / infantile sudden cardiac failure.

The local entry does not yet represent the IEMbase-specific acute infantile presentation, lactic-acidosis signal, seizures, arrhythmia, or sudden-death phenotype as a PPA2-centered disease mechanism.

Concordance and completeness

Judgement: generated false negative for partial local coverage, but exact PPA2 deficiency remains a local gap.

DisMech and IEMbase agree that PPA2 is relevant to recessive cardiac disease, but the local coverage is embedded in broad dilated cardiomyopathy. The IEMbase record is more specific: a mitochondrial pyrophosphatase defect with infantile sudden cardiac failure and metabolic-decompensation features.

Curation actions

  • Use Dilated_Cardiomyopathy.yaml#PPA2 as partial context only.
  • Create or identify an exact PPA2 mitochondrial pyrophosphatase deficiency / infantile sudden cardiac failure target before import, or add a clearly scoped PPA2 subtype if that matches project modeling decisions.
  • Preserve increased lactate, lactic acidosis, seizures, cardiac arrhythmia, and sudden death as PPA2-specific review prompts.